Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE): The Role of Angiotensin-(1-7) in Hypertension and Hypertension-Induced Heart and Kidney Damage

NCT04752293 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04752293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04752293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE): The Role of Angiotensin-(1-7) in Hypertension and Hypertension-Induced Heart and Kidney Damage
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2021
Completion date
December 31, 2026
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, angiotensin hypertension, autonomic dysfunction, autonomic imbalance, blood pressure disorders, hypertension, kidney diseases, kidney dysfunction, kidney injury, left atrial dilatation, left ventricular diastolic dysfunction, left ventricular dysfunction, left ventricular hypertrophy, pediatric kidney disease, pediatric obesity, proteinuria, sodium urine high, uric acid retention